Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AgeX Therapeutics, Inc. Common Stock (NY:AGE)

N/A UNCHANGED
Last Price Updated: 8:00 PM EDT, Mar 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AgeX Therapeutics, Inc. Common Stock

< Previous 1 2 Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning, trader! It's time to kick off another day with a dive into the biggest pre-market stock movers for Tuesday! 
Via InvestorPlace
61 Biggest Movers From Yesterday
Gainers Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa... 
Via Benzinga
35 Stocks Moving In Monday's Mid-Day Session
Gainers Immix Biopharma, Inc. (NASDAQ: IMMX) shares climbed 110.3% to $7.32. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-... 
Via Benzinga
18 Stocks Moving in Monday's Pre-Market Session
Gainers Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) rose 41.6% to $3.13 in pre-market trading after gaining around 8% on Friday. Armstrong Flooring, Inc. (NYSE: AFI... 
Via Benzinga
40 Biggest Movers From Friday
Gainers Nutriband Inc. (NASDAQ: NTRB) shares climbed 157.8% to close at $10.08 on Friday after the company announced the Korean Intellectual Property Office has fully issued its... 
Via Benzinga
Braeden Lichti: The Business of Anti-Aging and Rejuvenation Biotechnology
VANCOUVER, British Columbia - Dec. 31, 2021 - PRLog -- 2020-07-30: Scientists now have a better understanding into the aging process, giving us a better explanation of the cellular changes that lead... 
Via PRLog
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
AgeX Therapeutics to Collaborate With University of California, Irvine, on Research Program for Exosome-Based Therapies for Certain Brain Disorders
From AgeX Therapeutics, Inc.
Via Business Wire
AgeX Therapeutics’ Licensee ImStem Biotechnology Announces First U.S. Multiple Sclerosis Patient Dosed with IMS001
From AgeX Therapeutics, Inc.
Via Business Wire
The Daily Biotech Pulse: Kura's Blood Cancer Drug Study Gets Partial Clinical Hold, Takeda FDA Nod, Puma Breast Cancer Treatment Gets Patent Extension
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Puma Biotech Announces Receipt Of Patent Extension For Breast Cancer Drug By... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property Product Safety
AgeX Therapeutics Receives Stock Exchange Deficiency Letter
From AgeX Therapeutics , Inc.
Via Business Wire
AgeX Therapeutics Reports Third Quarter 2021 Financial Results
From AgeX Therapeutics, Inc.
Via Business Wire
AgeX Therapeutics Reports Second Quarter 2021 Financial Results
From AgeX Therapeutics, Inc.
Via Business Wire
A Peek Into The Markets: US Stock Futures Down Following Friday's Rally
Pre-open movers U.S. stock futures traded lower in early pre-market trade after all three major indexes settled at record highs in the previous session. China announced a set of... 
Via Benzinga
5 Stocks To Watch For July 26, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Lockheed Martin Corporation (NYSE: LMT) to report quarterly earnings at $6.53 per share on revenue... 
Via Benzinga
AgeX Therapeutics and LyGenesis Terminate Merger Negotiations
From AgeX Therapeutics, Inc.
Via Business Wire
AgeX Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
From AgeX Therapeutics
Via Business Wire
58 Biggest Movers From Yesterday
Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) shares jumped 104.2% to close at $8.70 on Monday after the company announced the full details of its Phase 2 trial... 
Via Benzinga
38 Stocks Moving In Monday's Mid-Day Session
Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) surged 46.9% to $6.25 after the company announced the full details of its Phase 2 trial evaluating its lead drug... 
Via Benzinga
21 Stocks Moving in Monday's Pre-Market Session
Gainers Ocugen, Inc. (NASDAQ: OCGN) shares rose 20.6% to $11.61 in pre-market trading. Ocugen’s COVID-19 vaccine partner, India-based Bharat Biotech International Ltd.,... 
Via Benzinga
Exposures COVID-19
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS